Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

By sjmartinez • November 19, 2024

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiol. 2024 Nov 18:e244489. doi: 10.1001/jamacardio.2024.4489. Epub ahead of print. PMID: 39556474; PMCID: PMC11574726.

Tags: Cardiology/Epi, Publications

Central Adiposity and Inflammation Mediate the Association Between Ultraprocessed Food Intake and Cardiovascular Disease Risk

Haidar A, Flynn S, Rikhi R, Watson KE, Wood AC, Shapiro MD. Central Adiposity and Inflammation Mediate the Association Between Ultraprocessed Food Intake and Cardiovascular[...]

Temporal and Regional Trends in Cardiovascular Mortality Associated With Diabetes Mellitus: A Nationwide Analysis From 1999 to 2020 in the United States

Ahmed S, Ahmed S, Ahmad E, Ashraf H, Akram U, Ahmad S, Uwishema O, Hassan IN, Ullah I, Ata F, Cheema AH, Alraies C, Fonarow[...]

A Polypill Strategy to Close the Heart Failure Treatment Gap

Fonarow GC, McMurray JJV. A Polypill Strategy to Close the Heart Failure Treatment Gap. JAMA Cardiol. 2026 Sep 30. doi: 10.1001/jamacardio.2026.3727. Epub ahead of print.[...]